In conjunction with its appearance at Eurospine 2014 in Lyon, France, NuVasive, Inc. is the opening of the company’s European Center of Excellence (COE) in Amsterdam.
NuVasive Opens Center of Excellence in Amsterdam
1 min read Premium comments
Secondary
According to the October 1, 2014 news release, “The center will serve as NuVasive’s European commercial headquarters and function as the commercial hub for the European executive leadership and departments across marketing, surgeon education, sales, human resources, legal and other support functions. Meanwhile, the International Operations Center in Ireland, which was established in June, will remain the company’s international operational headquarters.”
Paul Kosters, senior vice president of the EMEA branch said in the news release, “The opening of the COE is an important milestone for NuVasive and a key inflection point for our Company’s strategy to expand in EMEA. In the past year, we have expanded our footprint to include Spain and Poland. Additionally, we continued to build out our world-class leadership team in EMEA with the recent appointment of Phil Bradshaw as Managing Director for the United Kingdom. Phil brings nearly 20 years of experience in the medical device industry, including a decade with DePuy Synthes and most recently with Stryker. Phil’s extensive experience in various markets across Europe will be highly complementary as we continue to execute against our market share-taking strategy.”
Kosters told OTW, “Our initiatives in both Spain and Poland are focused on expanding our footprint in these important markets and establishing a sales and distribution network.”
Regarding the COE, Kosters commented, “The Center of Excellence in Amsterdam will function as a European management office for corporate functions and as a surgeon Education Center. The COE will better position us to realize our vision of serving the needs of patients and surgeons in Europe while also driving innovation in minimally disruptive surgical products and procedures throughout the region. We will also pursue our commitment to surgeon education and plan to train surgeons through workshops on Minimal Invasive (Maximal Access) surgery through cadaveric courses and workshops.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.